Amferia

Amferia AB is a startup company that aims to market new medical devices with emphasis on antibacterial products. One of the core focus of Amferia is preventive healthcare where the goal is to develop materials that can efficiently prevent bacterial infections when used as medical devices, for example within wound care or injectable fillers. Amferia is a spin-off from research performed in Professor Martin Andersson’s group at Chalmers University of Technology. The company was founded in 2018 and the founders of Amferia are Dr. Anand Kumar Rajasekharan, Professor Martin Andersson and Ms. Saba Atefyekta.

Company’s Keywords:

antibacterial materials, antibiotic resistance, elastomers, injectable materials